Anne Meneghetti, MD, highlights the misconceptions that drive individuals to seek antibiotics for common colds sooner than necessary.
In a recent survey conducted by Epocrates, a surprising trend emerged regarding people's expectations and perceptions about the common cold. To shed light on these findings and discuss their implications, Infection Control Today® (ICT®), sits down with Anne Meneghetti, MD, the executive director of medical information at Epocrates. She shares insights from the survey, revealing how misconceptions about the duration and treatment of cold symptoms impact health care decisions.
Meneghetti told ICT that because the media has discussed long COVID so often recently, she suspected that individuals may not understand how long a cold normally lasts. She is speaking of the “typical symptoms such as sneezing, runny nose, sore throat, congestion, and cough.” Epocrates’ recent survey verified her hunch.
“And so we did this survey of 1000 adults to ask them, ‘How long do you think a cold should last? And how long before you get concerned that something's wrong and that you need to seek care, etc?’ And the results were surprising. Typically, a cold should last anywhere up to 10 to 14 days. And yet, most people have a much different impression. Usually, [they believe] cold symptoms will peak around 2 to 3 days, and then the results start getting better and resolving.”
However, Meneghetti said that isn’t correct. “And yet, especially cough, nasal congestion, and runny nose can persist for 10 to 14 days. And I don't think a lot of people realize that. So, as time goes on, many people begin to think something is wrong and [that] they need an antibiotic. When we surveyed these 1000 adults, 43% of them expected that a cold [should] be gone within 5 days, and 35% more expected a cold to maybe last a week. And only 6% believed that cold symptoms should last up to 14 days.”
Then, ICT and Meneghetti discussed why these misconceptions seem to linger and how prescribing antibiotics when they are not needed affects antimicrobial resistance [AMR]. She believed it is because “I do think that it's quicker to write a prescription than it is to explain all these things. But what this survey shows is that 70% of people are sensitive to the concept that taking an antibiotic unnecessarily might not only harm them in terms of side effects or drug interactions but taking an antibiotic unnecessarily contributes to antimicrobial resistance for their future, their community's future, [and] for their loved ones’ future. And that's really heartening that hearing [about AMR] makes a difference to them. And it does take more time and writing a prescription for sure.”
To find out more about AMR, check out ICT's coverage, including this ICT article.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.